GlassScriptPhysician profile
James Thomas Sheller
NPI 1154915346
$883.78
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $289 · 2022: $146 · 2023: $172 · 2024: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $346.05 | 2021-2023 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $134.49 | 2021-2024 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $121.38 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $110.91 | 2023-2024 | Hawkone |
| Novartis Pharmaceuticals Corporation | $43.27 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $31.94 | 2021 | |
| Celgene Corporation | $29.08 | 2024 | Reblozyl |
| Amryt Pharma Holdings LTD | $22.13 | 2021 | |
| Merck Sharp & Dohme LLC | $19.50 | 2021 | |
| Amgen INC. | $13.37 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sheller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.